Athira Pharma - ATHA Balans kapitallashuvi
Athira Pharma, Inc. (ATHA) Altsgeymer kasalligida kognitiv qobiliyatlarni tiklash uchun neyron aloqalarini regeneratsiya qilishning innovatsion usullarini ishlab chiqmoqda. Uzoq muddatli rivojlanish uchun moliyalashtirish mavjud naqd pul zaxiralariga tayanadi va joriy ko'rsatkich 0.03 ni tashkil etadi. Kompaniya aksiyalarining ushbu narxlar grafigi kapital xarajatlarini kamaytirish uchun moddalar sintezi va sinovlar uchinchi tomon pudratchilariga topshirilgan biznes modelini ko'rsatadi.
%20Kompaniyaning%20balans%20qiymati&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_ATHA_-_Athira-Pharma-Inc._-_Company-Book-Value "Athira Pharma Inc (ATHA) Buxgalteriya kapitallashuvi: 04.07.2022 - 12.01.2026 davri uchun | 👁️GURU.Markets👁️")
Athira Pharma (ATHA) kompaniyasi koʻrsatkichlari kesimi va tahlili
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati Athira Pharma, Inc.|ATHA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati Athira Pharma Inc|ATHA - Kompaniya qarzlari|Balans qiymatiga qarzlar Athira Pharma Inc|ATHA - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzlari Athira Pharma
Kompaniyaning jamlanma tahlili:ATHA - Athira Pharma Corp
Kitob kapitalizatsiyasi sof aktivlarning real qiymatini aks ettirib, operatsion jarayonlarni moddiy aksiyadorlar kapitaliga aylantirish samaradorligini namoyish etadi. Alzheimer kasalligi dori vositalarini insonparvarlik asosida ishlab chiqishining barqaror AQSh sog'liqni saqlash standartlariga bog'liq bo'lgan Athira Pharma, Inc. (ATHA) uchun GURU.Markets platformasida kompaniyaning kitob kapitalizatsiyasini tahlil qilish, geosiyosiy tebranishlardan qat'i nazar, biznesning moliyaviy fundamental barqarorligini baholash imkonini beradi.
Athira Pharma, Inc. raqobatchilari tahlili
BIIB - Kompaniyaning buxgalteriya qiymati|NBIX: Balans kapitallashuvi|RGC (regencellbioscience.com) - Balans kapitallashuvi|Kompaniyaning balans qiymati Axsome Therapeutics, Inc. (AXSM)|Buxgalteriya kapitallashuvi ACADIA Pharma|Xenon Pharmaceuticals Inc - Balans kapitallashuvi|Kompaniyaning xususiy kapitali Viking Therapeutics Corp VKTX|Kompaniyaning sof aktivlari SUPN (Supernus Pharmaceuticals)|catalystpharma.com - Balans kapitallashuvi|Kompaniyaning balans qiymati Denali Therapeutics Inc. (DNLI)|HRMY: Kompaniyaning buxgalteriya qiymati|Kompaniyaning balans qiymati BHVN|Amylyx Corp (AMLX) - Kompaniyaning xususiy kapitali|TRVI (Trevi Therapeutics) - Balans kapitallashuvi|Balans kapitallashuvi praxismedicines.com (PRAX)|Kompaniyaning sof aktivlari Anavex Life Sciences Corp.|Jami sof aktivlar CeriBell Inc (CBLL)|Balans kapitallashuvi prothena.com|Kompaniyaning buxgalteriya qiymati Alector Inc. ALEC|Balans kapitallashuvi ANNX (Annexon, Inc.)|OMER: Biznesning balans bahosi|Kompaniyaning balans qiymati Neurogene NGNE|AC Immune S.A. (ACIU) - Kompaniyaning buxgalteriya qiymati|VYGR (Voyager Pharma) - Balans kapitallashuvi|Balans kapitallashuvi Neumora Corp (NMRA)|Scilex Holding Company (SCLX) - Kompaniyaning sof aktivlari|Kompaniyaning buxgalteriya qiymati TVGN (tevogen.com)|Alpha Cognition Inc. (ACOG) - Kompaniyaning balans qiymati|Sof aktivlar qiymati cogrx.com CGTX|Balans kapitallashuvi Inhibikase (IKT)|SAVA - Kompaniyaning buxgalteriya qiymati|ASRT: Balans kapitallashuvi|COYA (Coya Therapeutics) - Balans kapitallashuvi|VTGN - Kompaniyaning balans qiymati|Kompaniyaning buxgalteriya qiymati OVID|Kompaniyaning balans qiymati ABOS (Acumen Pharma)|Kompaniyaning sof aktivlari CervoMed Corporation (CRVO)|Balans kapitallashuvi ATHE (Alterity Therapeutics Limited)|CLNN - Balans kapitallashuvi|Kompaniyaning sof aktivlari PepGen Corp (PEPG)|JUNS - Kompaniyaning buxgalteriya qiymati|Relmada - Balans kapitallashuvi|ANVS (Annovis Bio Corporation) - Biznesning balans bahosi|Kompaniyaning balans qiymati Grace Therapeutics Inc (GRCE)|Buxgalteriya kapitallashuvi fireflyneuro.com|Balans kapitallashuvi KLTO (Klotho Neurosciences Inc)|Kompaniyaning sof aktivlari neurosense-tx.com NRSN|Kompaniyaning sof aktivlari RVPH|Biznesning balans bahosi MetaVia Inc. MTVA|NeurAxis, Inc. - Balans kapitallashuvi|Helius Medical (HSDT) - Balans kapitallashuvi|PASG - Kompaniyaning sof aktivlari|Neuphoria Therapeutics (NEUP) - Jami sof aktivlar|NERV - Balans kapitallashuvi|Kompaniyaning buxgalteriya qiymati Addex|Balans kapitallashuvi ALZN|Balans kapitallashuvi CYCN (cyclerion.com)|PTIX - Kompaniyaning balans qiymati|Buxgalteriya kapitallashuvi Pasithea Therapeutics Corp KTTA|CRGT (Cortigent Medical) - Balans kapitallashuvi|Avenue Therapeutics Inc (ATXI) - Kompaniyaning xususiy kapitali|BCLI: Kompaniyaning sof aktivlari|CARA (caratherapeutics.com) - Balans kapitallashuvi|CHRO - Kompaniyaning balans qiymati|Kompaniyaning buxgalteriya qiymati ELYM|Intra-Cellular Therapies - Kompaniyaning balans qiymati|Kompaniyaning xususiy kapitali Longboard (LBPH)|Balans kapitallashuvi MRNS (Marinus Pharmaceuticals)|NKGN - Balans kapitallashuvi|Kompaniyaning sof aktivlari NeuroBo Pharmaceuticals, Inc. NRBO|SAGE - Jami sof aktivlar|Balans kapitallashuvi Neurotrope SNPX|Trevena Inc (TRVN) - Kompaniyaning buxgalteriya qiymati|VIGL: Balans kapitallashuvi|Biznesning balans bahosi WENA|Cerevel Therapeutics, Inc. (CERE) - Kompaniyaning balans qiymati